Tokyo, June 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061698) titled 'A Study on the Ratio of Oxidized to Reduced Albumin in Dialysis Patients' on June 1.
Study Type:
Observational
Primary Sponsor:
Institute - Kawashima Hospital
Condition:
Condition - Dialysis patients
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To identify the factors influencing the oxidized-reduced albumin ratio in dialysis patients.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 20
years-old
=
Gender - Male and Female
Key inclusion criteria - Dialysis patients receiving treatment at Kawashima Hospital
Key exclusion criteria - Patients without their consent
Target Size - 600
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2024 Year 08 Month 01 Day
Date of IRB - 2025 Year 04 Month 08 Day
Anticipated trial start date - 2024 Year 10 Month 01 Day
Last follow-up date - 2035 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070599
Disclaimer: Curated by HT Syndication.
